Guerriero I, Monaco G, Coppola V, Orlacchio A. Serum and Glucocorticoid-
Inducible Kinase 1 (SGK1) in NSCLC Therapy. Pharmaceuticals (Basel). 2020 Nov 22;13(11):413. doi: 10.3390/ph13110413. PMID: 33266470; PMCID: PMC7700219.
Soliman SHA, Stark AE, Gardner ML, Harshman SW, Breece CC, Amari F, Orlacchio A, Chen M, Tessari A, Martin JA, Visone R, Freitas MA, La Perle KMD, Palmieri D, Coppola V. Tagging enhances histochemical and biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin. Sci Rep. 2020 Apr 28;10(1):7138. doi: 10.1038/s41598-020-64047-8. PMID: 32346083; PMCID:PMC7188826.
Tessari A, Soliman SHA, Orlacchio A, Capece M, Amann JM, Visone R, Carbone DP, Palmieri D, Coppola V. RANBP9 as potential therapeutic target in non-small
cell lung cancer. J Cancer Metastasis Treat. 2020;6:18. doi: 10.20517/2394-4722.2020.32. Epub 2020 Jun 24. PMID: 34778565; PMCID: PMC8589326.
Huffman N, Palmieri D, Coppola V. The CTLH Complex in Cancer Cell Plasticity.
J Oncol. 2019 Nov 30;2019:4216750. doi: 10.1155/2019/4216750. PMID: 31885576; PMCID: PMC6907057.
Orlacchio A, Stark AE, Foray C, Amari F, Sheetz T, Reese E, Tessari A, La
Perle K, Palmieri D, Tsichlis PN, Coppola V. Genetic ablation of interacting
with Spt6 (Iws1) causes early embryonic lethality. PLoS One. 2018 Sep
12;13(9):e0201030. doi: 10.1371/journal.pone.0201030. PMID: 30208029; PMCID: PMC6135376.
Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A,
Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, La Perle K, Farina G, Cole S, Marabese M, Hernandez M, Amann JM, Pruneri G, Carbone DP, Garassino MC, Croce CM, Palmieri D, Coppola V. RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients. Oncogene. 2018 Dec;37(50):6463-6476. doi: 10.1038/s41388-018-0424-8. Epub 2018 Aug 3. PMID: 30076413; PMCID: PMC6690599.
Palmieri D, Tessari A, Coppola V. Scorpins in the DNA Damage Response. Int J
Mol Sci. 2018 Jun 17;19(6):1794. doi: 10.3390/ijms19061794. PMID: 29914204;
PMCID: PMC6032341.
Puverel S, Kiris E, Singh S, Klarmann KD, Coppola V, Keller JR, Tessarollo L.
RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells. Oncotarget. 2016 Dec
20;7(51):85109-85123. doi: 10.18632/oncotarget.13198. PMID: 27835883; PMCID: PMC5341297.
Palmieri D, Scarpa M, Tessari A, Uka R, Amari F, Lee C, Richmond T, Foray C,
Sheetz T, Braddom A, Burd CE, Parvin JD, Ludwig T, Croce CM, Coppola V. Ran
Binding Protein 9 (RanBP9) is a novel mediator of cellular DNA damage response in lung cancer cells. Oncotarget. 2016 Apr 5;7(14):18371-83. doi:
10.18632/oncotarget.7813. PMID: 26943034; PMCID: PMC4951294.